IA
GDRX icon

Inspire Advisors’s GoodRx Holdings GDRX Stock Holding History

Inspire Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,632
Closed -$157K – 219
2022
Q4 		$157K Buy
33,632
+314
+0.9% +$1.55K 0.04% 163
2022
Q3 		$156K Buy
+33,318
New +$210K 0.04% 132

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Inspire Advisors's GDRX Position: Q1 2023 in Review

Inspire Advisors sold out of GoodRx Holdings (GDRX) in Q1 2023, closing a stake of 33,632 shares — an estimated $157K sold.

Inspire Advisors first reported a position in GDRX in Q3 2022 and held it in 2 quarters. The position peaked at $157K in Q4 2022. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

  • Inspire Advisors reported no remaining GoodRx Holdings position as of Q1 2023 after selling out during the quarter.
  • Inspire Advisors sold 33,632 GoodRx Holdings shares in Q1 2023, an estimated $157K.
  • Inspire Advisors first reported a position in GoodRx Holdings in Q3 2022 and held it in 2 quarters.
  • Inspire Advisors's GoodRx Holdings position peaked at $157K in Q4 2022.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on Inspire Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.